Correction: Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union
Ther Innov Regul Sci
.
2024 Jul;58(4):687-688.
doi: 10.1007/s43441-024-00653-2.
Authors
Mohammed Alnuhait
1
,
Abdullah Alshammari
2
,
Manar Alharbi
2
,
Lina Alotaibi
2
,
Reem Alharbi
2
,
Attiah Khobrani
3
,
Nora Alkhudair
4
,
Majed Alshamrani
5
,
Abdullah M Alrajhi
6
7
Affiliations
1
Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
[email protected]
.
2
Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
3
Pharmaceutical Care Services, King Abdullah Medical City, Makkah, Saudi Arabia.
4
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
5
Department of Pharmaceutical Care Services, King Abdulaziz Medical City (KAMC), Jeddah, Saudi Arabia.
6
Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia.
7
Department of Pharmacy Practice, College of Pharmacy, AlFaisal University, Riyadh, Saudi Arabia.
PMID:
38625647
DOI:
10.1007/s43441-024-00653-2
No abstract available
Publication types
Published Erratum